Citicoline(CDP Choline) Sodium Nootropic powder (33818-15-4) for Sale

www.wisepowder.com

wise12@wisepowder.com

Citicoline(CDP Choline) Sodium Nootropic powder (33818-15-4) for Sale 01

Overview

Citicoline Sodium (CDP-choline Sodium, cytidine 5'-diphosphocholine) powder is a water soluble nutrient which serves as a precursor to both choline and cytidine within the brain (which later converts to uridine). To humans,Citicoline Sodium is an essential nutrient as its role in reducing the riskof neural tube defects, fatty liver disease, and other pathologies have been documented. CDP-choline Sodium is one of the three choline-containing phospholipids that can be orally supplemented (the other two being alpha-GPC and phosphatidylcholine).

1/5

www.wisepowder.com

wise12@wisepowder.com

02 Citicoline(CDP Choline) Sodium powder (33818-15-4) video 03 Citicoline(CDP Choline) Sodium powder (33818-15-4) Base Information Name

Citicoline Sodium (CDP Choline Sodium) powder

CAS

33818-15-4

Purity

98%

Chemical name

Citicoline Sodium; Cdp-choline sodium

Synonyms

Sodium [[(2S,3R,4S,5S)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxol an-2-yl]methoxy-oxidophosphoryl]2-(trimethylazaniumyl)ethyl phosphate

Molecular Formula

C14H25N4NaO11P2

Molecular Weight

510.308g/mol

Melting Point

>240°C

InChI Key

YWAFNFGRBBBSPD-KDVMHAGBSA-M

Form

Solid

Appearance

White Solid powder

Half Life

56

Solubility

Soluble in DMSO, Water (Slightly)

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Application

Citicoline Sodium is a neuroprotective agent and dietary supplement

Testing Document

Available

hours

04 Citicoline(CDP Choline) Sodium powder (33818-15-4) General Description 2/5

www.wisepowder.com

wise12@wisepowder.com

Citicoline Sodium powder is a complex organic molecule that functions as an intermediate in the biosynthesis of cell membrane phospholipids. CiticolineSodium is also known as CDP-choline Sodium and Cytidine 5′-diphosphocholine sodium.

CDP-choline Sodium belongs to the group of biomolecules in living systems known as “nucleotides” that play important roles in cellular metabolism.

CDP-choline Sodium is composed of ribose, pyrophosphate, cytosine (a nitrogenous base), and choline. Exogenous citicoline research in animal experiments and human clinical trials provides evidenceof its cholinergic and neuroprotective actions. As a dietary supplement, citicoline appears useful for improving both the structural integrity and functionality of the neuronal membrane that may assist in membrane repair. Animal and clinical studies indicate the potential of citicoline to improve cognitive deficits, stroke rehabilitation, brain and spinal cordinjuries, neurological diseases, and eye conditions.

This supplement is also catered towards preventing or treating memory impairments associated with aging because both of the molecules it confers are neuroprotective and potentially enhance learning. This effect mayalso benefit younger populations as well. It appears to be more efficientthan phosphatidylcholine (PC) itself in this role, in part due to also increasing PC synthesis in the brain.

05 Citicoline(CDP Choline) Sodium powder (33818-15-4) History Citicoline Sodium (CDP Choline Sodium) is a brain chemical that occursnaturally in the body. As a medicine, it is taken by mouth as a supplement or given by IV or as a shot. Citicoline Sodium (CDP Choline Sodium) is used for Alzheimer’s disease and other types of dementia, head trauma, cerebrovascular disease such as stroke, age-related memory loss, Parkinson’s disease, attention deficit-hyperactive disorder (ADHD), and glaucoma. Citicoline Sodium (CDP Choline Sodium) was originally developed in Japan for stroke.It was later introduced as a prescription drug in many European countries. In these countries it is now frequently prescribed for thinking problems related to circulation problems in the brain. In the US, Citicoline Sodium (CDP Choline Sodium) is marketed as a dietary supplement.

06 Citicoline(CDP Choline) Sodium powder (33818-15-4) Mechanism Of Action Citicoline is the generic name of the pharmaceutical substance that chemically is cytidine-5′-diphosphocholine (CDP-choline), which is identical to the natural intracellular precursor of phospholipid phosphatidylcholine.Following injection or 3/5

www.wisepowder.com

wise12@wisepowder.com

ingestion, citicoline is believed to undergo quick hydrolysis and dephosphorylation to yield cytidine and choline, which then enter the brain separately and are used to resynthesize CDP-choline inside brain cells. Citicoline seems to increase a brain chemical called phosphatidylcholine. This brain chemical is important for brain function. Citicoline might also decrease brain tissue damage when the brain is injured.

07 Citicoline(CDP Choline) Sodium powder (33818-15-4) Application Citicoline Sodium (CDP Choline Sodium) powder is a neuroprotective agent. It acts by enhancing cellular communication, stimulating the synthesis of SAMe, and increasing glucose metabolis. Citicoline Sodium (CDP Choline Sodium) powder is a naturally occurring nucleotide; intermediate in the major pathway of lecitin biosynthesis.

Neuroprotective. It is used in the treatment of ischemic stroke and head trauma.

Neuroprotectiveproduct. Citicholine exhibits protective effects in cerebral ischemia, traumatic brain injury, and memory disorders. Recently showed efficacy against dementia when given with AchEIs (Acetylcholinesterase inhibitor). Depicts Neuroprotective, acnticonvulsant activity and sedative effect at a dose of 150mg/kg in rats. Showed protection against aluminum induced cognitive impairment in rats reducing elevated glutamate level, oxidativestress and NO overproduction in the hippocampus.

08 Citicoline(CDP Choline) Sodium powder (33818-15-4) More Research Citicoline Sodium (CDP-choline; cytidine 5′-diphosphocholine) has a broad spectrum of benefits for conditions associated with symptoms of neurological dysfunction shows promise of clinical efficacy in elderly patients with cognitive deficits, inefficient memory, and early-stage Alzheimer’s disease. Citicoline Sodium has also been investigated as a therapy in stroke patient. Despite it was approved in some countries for treatment Traumatic Brain Injury (TBI), the use of this drug for acute TBI seems to have no field of support anymore, whereas it may have some benefits in improving the neuro-cognitive state in chronic TBI patients. It’s also recommended to keep in mind acute interventions like Psychological First Aid (PFA) during acute TBI management. Citicoline Sodium plays several important roles in human physiology, including enhancement of structural integrity and signaling for cell membranes, support of acetylcholine synthesis, and synthesisof betaine, a methyl donor. The precise mechanism of action of Citicoline Sodium to treat disease is unknown, but was confirmed, that drug might increase phosphatidylcholine (PtdCho) synthesis and 4/5

www.wisepowder.com

wise12@wisepowder.com

might reverse PtdCho loss. In addition, was shown, that citicolinemodulates phospholipids metabolism and neurotransmitter levels and appears to improve cognition insome central nervous system disorders such as bipolar disorder and cocaine dependence.

09 Citicoline(CDP Choline) Sodium powder (33818-15-4) Document Download COA

10 Citicoline(CDP Choline) Sodium powder (33818-15-4) Reference 1: Tyurenkov IN, Kurkin DV, Bakulin DA, Volotova EV, Chafeev MA. [Cerebroprotective activity of metformin, gosogliptin, citicoline and a novel GPR119 agonist in cerebral ischemia under experimental diabetes mellitus]. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(12. Vyp. 2):53-59. doi: 10.17116/jnevro201711712253-59. Russian. PubMed PMID: 29411746.

2: Jiang JJ, Xie YM, Zhang Y, Zhang YK, Wang ZM, Han B. [Clinical medication characteristics of Shuxuening injection in treatment of cerebral infarction research based on registration]. Zhongguo Zhong Yao Za Zhi. 2016 Dec;41(24):4516-4520. doi: 10.4268/cjcmm20162407. Chinese. PubMed PMID: 28936832.

3: Liu Y, Wang J, Xu C, Chen Y, Yang J, Liu D, Niu H, Jiang Y, Yang S, Ying H. Efficient multi-enzyme-catalyzed CDP-choline production driven by an ATP donor module.

Appl Microbiol Biotechnol. 2017 Feb;101(4):1409-1417. doi: 10.1007/s00253-016-7874-0. Epub 2016 Oct 13. PubMed PMID: 27738720.

4: Zhang LN, Sun YJ, Pan S, Li JX, Qu YE, Li Y, Wang YL, Gao ZB. Naâ ş-Kâ ş-ATPase, a potent neuroprotective modulator against Alzheimer disease. Fundam Clin Pharmacol. 2013 Feb;27(1):96-103. doi: 10.1111/fcp.12000. Epub 2012 Oct 3. Review.

PubMed PMID: 23033963.

5/5